AbbVie and Alvotech settle all US Humira litigation

10-03-2022

Alex Baldwin

AbbVie and Alvotech settle all US Humira litigation

Piotr Swat / Shutterstock.com

AbbVie and Icelandic biosimilar company Alvotech have settled all US litigation over Alvotech’s proposed generic of AbbVie’s blockbuster arthritis treatment Humira (adalimumab).


AbbVie, Alvotech, Humia, International Trade Commission, generic, biosimilar, US

LSIPR